Maya Biotech -- Top Pharma Manufacturers in India
Maya Biotech Pvt. Ltd is one of the India's fastest growing pharmaceutical companies and part of Maya Biotech Genesis and is also one of the Top Pharma Manufacturers in India. Maya Biotech Pvt. Ltd. introduces as a leading & trusted brand in the pharmaceutical Contract Manufacturing Industry. It is established as a humble drug formulation and Manufacturing unit at Baddi the industrial hub of Himachal Pradesh (India).
Maya Biotech have 3 manufacturing Facilities in H.P. beside our Domestic Market have 30% Production is Exported to various countries. We are one of the oldest Manufacturing Unit with 20 yrs of Manufacturing experience .
The company has setup its plant in Himachal Pradesh (serving leading pharma companies of India) there by providing a cost competitive edge over manufacturing unit operating in other parts of the country. Maya Biotech is engaged in manufacturing and marketing Pharmaceutical and Health Care products With a network of organized tie-ups for a wide array of close to 500 products, Maya Biotech is growing leaps and bounds today and known as a quality conscious and conscientious drug manufacturer of India and comes as an ideal partner for Contract Manufacturing of Critical Care Higher Injectables with best stability.
We are working hard to improve the quality of life by enabling people to do more, feel better and live longer. This drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions. With these, we have gained the position in the Top Pharma Manufacturers in India.
Relation Between Pharma and Biotech
Unlike in other countries, the difference between biotechnology and pharmaceuticals remains fairly defined in India, with biotech a much smaller part of the economy. India accounted for 2% of the $41 billion global Biotech market and in 2003 was ranked 3rd in the Asia-Pacific region and 13th in the world in number of biotech. In 2004-5, the Indian biotech industry saw its revenues grow 37% to $1.1 billion. The Indian Biotech market is dominated by bio pharmaceuticals; 76% of 2004–5 revenues came from bio-pharmaceuticals, which saw 30% growth last year. Of the revenues from bio-pharmaceuticals, vaccines led the way, comprising 47% of sales.
Biologics and large-molecule drugs tend to be more expensive than small-molecule drugs, and India hopes to sweep the market in bio-generics and contract manufacturing as drugs go off patent and Indian companies upgrade their manufacturing capabilities. Most companies in the biotech sector are extremely small, with only two firms breaking 100 million dollars in revenues. At last count there were 265 firms registered in India, over 92% of which were incorporated in the last five years. The newness of the companies explains the industry’s high consolidation in both physical and financial terms. Almost 30% of all Biotech are in or around Bangalore, and the top ten companies capture 47% of the market.